Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Semra Paydas, Melek Ergin, Seyda Erdogan & Gulsah Seydaoglu. (2007) Cyclooxygenase-2 expression in non-Hodgkin's lymphomas. Leukemia & Lymphoma 48:2, pages 389-395.
Read now
Read now
Masahiko Ohsawa, Hiroko Fukushima, Yoshihiro Ikura, Takeshi Inoue, Nobuyuki Shirai, Yoshimi Sugama, Takehisa Suekane, Chizuko Kitabayashi, Hirohisa Nakamae, Masayuki Hino & Makiko Ueda. (2006) Expression of cyclooxygenase-2 in Hodgkin's lymphoma:its role in cell proliferation and angiogenesis. Leukemia & Lymphoma 47:9, pages 1863-1871.
Read now
Read now
Articles from other publishers (31)
Romana Masnikosa, David Pirić, Julia Maria Post, Zorica Cvetković, Snježana Petrović, Marija Paunović, Vesna Vučić & Laura Bindila. (2023) Disturbed Plasma Lipidomic Profiles in Females with Diffuse Large B-Cell Lymphoma: A Pilot Study. Cancers 15:14, pages 3653.
Crossref
Crossref
Mário Sousa-Pimenta, Maria Manuela Estevinho, Miguel Sousa Dias, Ângelo Martins & Letícia M. Estevinho. (2023) Oxidative Stress and Inflammation in B-Cell Lymphomas. Antioxidants 12:4, pages 936.
Crossref
Crossref
Lu Qi, Xiangyu Pan, Xuelan Chen, Pengpeng Liu, Mei Chen, Qi Zhang, Xiaohang Hang, Minghai Tang, Dan Wen, Lunzhi Dai, Chong Chen, Yu Liu & Zhengmin Xu. (2023) COX-2/PGE2 upregulation contributes to the chromosome 17p-deleted lymphoma. Oncogenesis 12:1.
Crossref
Crossref
Yolanda Kartika Asmarani, Supriatno & Tetiana Haniastuti. (2022) Effect of Meloxicam on the Proliferation and Apoptosis of the Raji Cell Line: an In Vitro Study. International Journal of Dentistry 2022, pages 1-7.
Crossref
Crossref
Talea Sana, Shaista Qayyum, Almas Jabeen, Bina S. Siddiqui, Sabira Begum, Rafat A. Siddiqui & Taibi B. Hadda. (2022) Isolation and characterization of anti-inflammatory and anti-proliferative compound, for B-cell Non-Hodgkin lymphoma, from Nyctanthes arbor-tristis Linn.. Journal of Ethnopharmacology 293, pages 115267.
Crossref
Crossref
Sandeep Abhijit Pattnaik, Somanath Padhi, Ashutosh Panigrahi & Gaurav Sharma. (2021) Cyclooxygenase 2 (Cox 2) Expression in Newly Diagnosed Plasma Cell Myeloma: A Clinicopathological and Immunohistochemical Study on 73 Cases from a Single Tertiary Care Center. Indian Journal of Hematology and Blood Transfusion 38:2, pages 235-245.
Crossref
Crossref
Y. Elborai, A. Elgammal, A. Salama, M. Fawzy, E. D. El-Desouky, I. Attia & L. M. Shalaby. (2020) Cyclooxygenase-2 expression as a prognostic factor in pediatric classical Hodgkin lymphoma. Clinical and Translational Oncology 22:9, pages 1539-1547.
Crossref
Crossref
Amen H. Zaky, Dalia Elsers, Rania Bakry, Mostafa Abdelwanis, Ola Nabih, Rania Hafez & Mahmoud Rezk. (2019) Prognostic Value of Accumulative Expression of COX-2 and p53 in Small and Diffuse Large B Cell Lymphoma. Pathology & Oncology Research 26:2, pages 1183-1190.
Crossref
Crossref
Jorge Castro-López, Antonio Ramis, Marta Planellas, Mariana Teles & Josep Pastor. (2018) Cyclooxygenase-2 immunoexpression in intestinal epithelium and lamina propria of cats with inflammatory bowel disease and low grade alimentary lymphoma. BMC Veterinary Research 14:1.
Crossref
Crossref
Jorge Castro-López, Mariana Teles, Camino Fierro, Karin Allenspach, Marta Planellas & Josep Pastor. (2017)
Pilot study: duodenal
MDR1
and
COX2
gene expression in cats with inflammatory bowel disease and low-grade alimentary lymphoma
. Journal of Feline Medicine and Surgery 20:8, pages 759-766.
Crossref
Crossref
YINGYING CUI, ZHENCHANG SUN, XIN LI, CHANGSEN LENG, LEI ZHANG, XIAORUI FU, LING LI, XUDONG ZHANG, YU CHANG, FEIFEI NAN, ZHAOMING LI, JIAQIN YAN, MINGZHI ZHANG, WENCAI LI, GUANNAN WANG, DANDAN ZHANG & YAOZHEN MA. (2016) Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma. Oncology Letters 11:1, pages 693-698.
Crossref
Crossref
Randall E. Harris. 2015. Ibuprofen. Ibuprofen
518
546
.
P. Asproni, M. Vignoli, S. Cancedda, F. Millanta, R. Terragni & A. Poli. (2014) Immunohistochemical Expression of Cyclooxygenase-2 in Normal, Hyperplastic and Neoplastic Canine Lymphoid Tissues. Journal of Comparative Pathology 151:1, pages 35-41.
Crossref
Crossref
SHU-PEI MA, MEI LIN, HAI-NING LIU & JIAN-XIAN YU. (2012) Lymphangiogenesis in non-Hodgkin’s lymphoma and its correlation with cyclooxygenase-2 and vascular endothelial growth factor-C. Oncology Letters 4:4, pages 695-700.
Crossref
Crossref
Nahum Puebla-Osorio, Yasuko Miyahara, Sreevidya Coimbatore, Alberto Y Limón-Flores, Nasser Kazimi, Stephen E Ullrich & Chengming Zhu. (2011) Induction of B-cell lymphoma by UVB Radiation in p53 Haploinsufficient Mice. BMC Cancer 11:1.
Crossref
Crossref
Shao-Liang Han, Jun Cheng, Xiu-Ling Wu, Zeng-Rong Jia, Peng-Fei Wang & Zhan-Wei Wang. (2011) The clinical significance of CD97, NF-kB and COX-2 ingastric MALT lymphomas. Journal of Biomedical Science and Engineering 04:07, pages 483-489.
Crossref
Crossref
Nagehan O Barisik, Suheyla Bozkurt, Mahmut Gumus, Isik Kaygusuz, Nimet Karadayi, Emine Bas, Mahmut Bayik & Tulay Tecimer. (2010) Expression and prognostic significance of cox-2 and p-53 in hodgkin lymphomas: a retrospective study. Diagnostic Pathology 5:1.
Crossref
Crossref
Semra Paydas, Melek Ergin, Gulsah Seydaoglu, Seyda Erdogan & Sinan Yavuz. (2009) Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature. Leukemia Research 33:12, pages 1627-1635.
Crossref
Crossref
Xigui Yang, Huazhi Zhang, Ling Wei & Liya Jia. (2009) The expression of cyclooxygenase-2 (COX-2) and p16 in non-Hodgkin’s lymphomas and its clinical significance. The Chinese-German Journal of Clinical Oncology 8:2, pages 104-109.
Crossref
Crossref
Safiye Aktaş, Aydanur Kargı, Nur Olgun, Gulden Diniz, Ayşe Erbay & Canan Vergin. (2008) Prognostic significance of cyclooxygenase-2 expression in pediatric Hodgkin and non-Hodgkin lymphomas with or without Epstein–Barr virus latent infection. Comparative Clinical Pathology 17:2, pages 125-131.
Crossref
Crossref
Birgit Hoeft, Nikolaus Becker, Evelin Deeg, Lars Beckmann & Alexandra Nieters. (2007) Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma. Cancer Causes & Control 19:2, pages 163-173.
Crossref
Crossref
Elizabeth P. Ryan, Timothy P. Bushnell, Alan E. Friedman, Irfan Rahman & Richard P. Phipps. (2007) Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells. Cancer Immunology, Immunotherapy 57:3, pages 347-358.
Crossref
Crossref
Andrey Sorokin. 2008. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
133
156
.
F.L. Queiroga, A. Alves, I. Pires & C. Lopes. (2007) Expression of Cox-1 and Cox-2 in Canine Mammary Tumours. Journal of Comparative Pathology 136:2-3, pages 177-185.
Crossref
Crossref
Su Jung Shim, Woo-Ick Yang, Eunah Shin, Woong Sub Koom, Yong Bae Kim, Jae Ho Cho, Chang Ok Suh, Joo Hang Kim & Gwi Eon Kim. (2007) Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type. International Journal of Radiation Oncology*Biology*Physics 67:1, pages 31-38.
Crossref
Crossref
Daniel Sliva & Rakesh Srivastava. 2007. Apoptosis, Cell Signaling, and Human Diseases. Apoptosis, Cell Signaling, and Human Diseases
239
262
.
Randall E. Harris. 2007. Inflammation in the Pathogenesis of Chronic Diseases. Inflammation in the Pathogenesis of Chronic Diseases
93
126
.
Rena Buckstein, Robert S. Kerbel, Yuval Shaked, Rakesh Nayar, Cindy Foden, Ruth Turner, Christine R. Lee, Diane Taylor, Liying Zhang, Shan Man, Sylvain Baruchel, Diana Stempak, Francesco Bertolini & Michael Crump. (2006) High-Dose Celecoxib and Metronomic “Low-dose” Cyclophosphamide Is an Effective and Safe Therapy in Patients with Relapsed and Refractory Aggressive Histology Non–Hodgkin's Lymphoma. Clinical Cancer Research 12:17, pages 5190-5198.
Crossref
Crossref
Brian L. Cohen, Pablo Gomez, Yohei Omori, Robert C. Duncan, Francisco Civantos, Mark S. Soloway, Vinata B. Lokeshwar & Bal L. Lokeshwar. (2006) Cyclooxygenase-2 (cox-2) expression is an independent predictor of prostate cancer recurrence. International Journal of Cancer 119:5, pages 1082-1087.
Crossref
Crossref
Elizabeth P. Ryan, Stephen J. Pollock, Kuljeet Kaur, Raymond E. Felgar, Steven H. Bernstein, Nicholas Chiorazzi & Richard P. Phipps. (2006) Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells. Clinical Immunology 120:1, pages 76-90.
Crossref
Crossref
Marco LadettoSonia ValletAndreas TrojanMaria Dell'AquilaLuigia MonitilloRosalba RosatoLoredana SantoDaniela DrandiAlessandra BertolaPatrizia FalcoFederica CavalloIrene RiccaFederica De MarcoBarbara MantoanBeata Bode-LesniewskaGloria PaglianoRoberto FranceseAlberto RocciMonica AstolfiMara CompagnoSara MarianiLaura GodioLydia MarinoMarina RuggeriPaola OmedèAntonio PalumboMario Boccadoro. (2005) Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome. Blood 105:12, pages 4784-4791.
Crossref
Crossref